化合物 (R)-ND-336 T61491
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
50 mg | 2252493-33-5 | ¥19,420.00 | 询底价 |
100 mg | 2252493-33-5 | ¥24,625.00 | 询底价 |
25 mg | 2252493-33-5 | ¥14,900.00 | 询底价 |
Product Introduction
Bioactivity
英文名: (R)-ND-336
描述: (R)-ND-336 is a highly potent and selective MMP-9 inhibitor, displaying a K i value of 19 nM. It also exhibits inhibitory activity against MMP-2 (K i = 127 nM) and MMP-14 (K i =119 nM). With its significant potential, (R)-ND-336 is being investigated in the field of diabetic foot ulcers (DFUs) research [1].
体外活性: (R)-ND-336 poorly inhibits other MMPs (K i >100 μM). (R)-ND-336 has a long residence time (the time the inhibitor is bound to MMP-9, calculated as 1/k off ) of 300 min [1]. A favorable IC50value of 143 μM afforded a therapeutic index (IC 50 /K i for MMP-9) ratio of 7530, indicating that (R)-ND-336 is not cytotoxic [1].
体内活性: (R)-ND-336 (50 μg/wound/day for 14 days) accelerates wound healing faster [1]. (R)-ND-336 has an AUC of 1.3 μM min after topical administration and 35 μM min following intravenous dosing, for an AUC top /AUC iv ratio of 3.7%, indicating minimal absorption after topical administration in db/db mice [1]. Animal Model: Female db/db mice (BKS.Cg-Dock7 m+/+ Lepr db /J, 8-weeks old, ~40 g body weight) [1] Dosage: 50 μg Administration: Wound; once a day for 14 days Result: Accelerated wound healing faster and showed complete inhibition of MMP-9.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
化合物 (R)-ND-336 T61491信息由TargetMol中国为您提供,如您想了解更多关于化合物 (R)-ND-336 T61491报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途